Intensive blood-pressure control in hypertensive chronic kidney disease

New England Journal of Medicine

Volumn 363, Issue 26, 2010, Pages 2564-2566

  Bursztyn, Michael ^a   Ben Dov, Iddo Z ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; HUMAN; LETTER; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY FAILURE; ETHNOLOGY; HYPERTENSION; NEGRO; NOTE; CLINICAL TRIAL; DISEASE COURSE; GENETIC VARIABILITY; HAZARD RATIO; NEPHROSCLEROSIS; OUTCOME ASSESSMENT;

AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; RENAL INSUFFICIENCY, CHRONIC;

APOLIPOPROTEIN;

EID: 78650604154     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1011419     Document Type: Letter

References (6)

1. Appel LJ, Wright JT Jr, Greene T, et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 2010;363:918-29.
2. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men: 16-year MRFIT findings. JAMA 1997;277:1293-8.
3. Pogue V, Rahman M, Lipkowitz M, et al. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 2009;53:20-7.
4. Davidson MB, Hix JK, Vidt DG, Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med 2006;166:846-52.
5. [Erratum, Arch Intern Med 2006;166:1619.]
6. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension 2007;49:1235-41.